A case of disseminated cryptococcal disease after Bruton tyrosine kinase inhibitor therapy: A brief review in the Australian context

• Nicholas Van Rooij, MD,
• Jesse Johnston, MBBS, FACD,
• Rohan Mortimore, MBBS, FRCPA,
• Ivan Robertson, MBBS, FACD

Affiliations

Nicholas Van Rooij, MD

The Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia; School of Medicine, Griffith University, Southport, Queensland, Australia; Faculty of Medicine, The University of Queensland, St Lucia, Queensland, Australia; Correspondence to: Nicholas Van Rooij, MD, The Royal Brisbane and Women's Hospital, Brisbane, Queensland 4006, Australia.

Jesse Johnston, MBBS, FACD

The Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia

Rohan Mortimore, MBBS, FRCPA

The Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia

Ivan Robertson, MBBS, FACD

The Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia